Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -13679.31% is 145% below its 5-year average of -5579.78%, near the high end of its 5-year range (-54400.00%–-254.62%).
17.67% above its 12-month average of -16615.93%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2024 (2024-06-30): -54400.00%.
EBITDA MARGIN
-13679.31%
EBITDA MARGIN AVG TTM
-16615.93%
EBITDA MARGIN AVG 3Y
-3448.59%
EBITDA MARGIN AVG 5Y
-5579.78%
EBITDA MARGIN AVG 10Y
-2644.72%
EBITDA MARGIN AVG 15Y
-1547.69%
EBITDA MARGIN AVG 20Y
-1410.14%
CURRENT VS TTM AVG
+17.67%
CURRENT VS 3Y AVG
-296.66%
CURRENT VS 5Y AVG
-145.16%
CURRENT VS 10Y AVG
-417.23%
CURRENT VS 15Y AVG
-783.85%
CURRENT VS 20Y AVG
-870.07%
BioCardia, Inc.
Market Cap
$15.78M
EBITDA Margin
-13679.31%
TTM Avg
-16615.93%
3Y Avg
-3448.59%
5Y Avg
-5579.78%
Market Cap
$15.68M
EBITDA Margin
-14633.33%
TTM Avg
-7486.14%
3Y Avg
-4543.27%
5Y Avg
-3157.51%
Market Cap
$15.58M
EBITDA Margin
4.51%
TTM Avg
10.73%
3Y Avg
12.51%
5Y Avg
13.49%
Market Cap
$15.30M
EBITDA Margin
-468.17%
TTM Avg
-602.06%
3Y Avg
-602.06%
5Y Avg
-23374.02%
Market Cap
$16.52M
EBITDA Margin
-579.88%
TTM Avg
-374.35%
3Y Avg
-344.55%
5Y Avg
-411.92%
Market Cap
$14.94M
EBITDA Margin
-29916.57%
TTM Avg
-29916.57%
3Y Avg
-29916.57%
5Y Avg
-29916.57%
Market Cap
$16.64M
EBITDA Margin
-82.81%
TTM Avg
-187.23%
3Y Avg
-342.47%
5Y Avg
-369.32%
Market Cap
$16.74M
EBITDA Margin
-65.27%
TTM Avg
-65.27%
3Y Avg
-407.18%
5Y Avg
-920.02%
Market Cap
$16.82M
EBITDA Margin
-1287.62%
TTM Avg
-2964.71%
3Y Avg
-1700.58%
5Y Avg
-1592.26%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $15.78M | -13679.31% | -16615.93% | -3448.59% | -5579.78% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -14633.33% | -7486.14% | -4543.27% | -3157.51% |
| Jin Medical International Ltd. (ZJYL)vs › | $15.58M | 4.51% | 10.73% | 12.51% | 13.49% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -468.17% | -602.06% | -602.06% | -23374.02% |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -579.88% | -374.35% | -344.55% | -411.92% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | -29916.57% | -29916.57% | -29916.57% | -29916.57% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -82.81% | -187.23% | -342.47% | -369.32% |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -65.27% | -65.27% | -407.18% | -920.02% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | -1287.62% | -2964.71% | -1700.58% | -1592.26% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | -61.90% | -71.95% | -80.60% | -87.82% |
Gross Margin
0.0%
EBITDA Margin
-13679.3%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2024-06-30 | -54400.00% |
| 2024-03-31 | -4101.82% |
| 2023-12-31 | -15876.92% |
| 2023-09-30 | -721.85% |
| 2023-06-30 | -7979.07% |
| 2023-03-31 | -5450.00% |
| 2022-12-31 | -2755.66% |
| 2022-09-30 | -1429.72% |
| 2022-06-30 | -254.62% |
| 2022-03-31 | -5518.33% |
| 2021-12-31 | -4362.03% |
| 2021-09-30 | -328.01% |
| 2021-06-30 | -5033.33% |
| 2021-03-31 | -6430.43% |
| 2020-12-31 | -7569.57% |
| 2020-09-30 | -11270.59% |
| 2020-06-30 | -13185.19% |
| 2020-03-31 | -11760.53% |
| 2019-12-31 | -1575.35% |
| 2019-09-30 | -1648.45% |
| 2019-06-30 | -4344.19% |
| 2019-03-31 | -1696.30% |
| 2018-12-31 | -3532.04% |
| 2018-09-30 | -4223.81% |
| 2018-06-30 | -1351.46% |
| 2018-03-31 | -1808.04% |
| 2017-12-31 | -3502.00% |
| 2017-09-30 | -2321.54% |
| 2017-06-30 | -2629.46% |
| 2017-03-31 | -2089.05% |
| 2016-12-31 | 245.24% |
| 2016-09-30 | 4384.62% |
| 2016-06-30 | 59.86% |
| 2016-03-31 | 61.07% |
| 2015-12-31 | 74.81% |
| 2015-09-30 | 79.34% |
| 2015-06-30 | 66.40% |
| 2015-03-31 | 63.24% |
| 2014-12-31 | 47.66% |
| 2014-09-30 | 43.75% |
| 2014-06-30 | 61.90% |
| 2014-03-31 | 75.51% |
| 2013-12-31 | 3.33% |
| 2013-09-30 | 36.62% |
| 2013-06-30 | 8.70% |
| 2013-03-31 | -68.42% |
| 2012-12-31 | -440.00% |
| 2012-09-30 | -436.84% |
| 2012-06-30 | -776.47% |
| 2012-03-31 | -527.27% |
| 2011-12-31 | -1225.00% |
| 2010-12-31 | -381.78% |
| 2010-09-30 | 22.44% |
| 2010-06-30 | -107.43% |
| 2010-03-31 | -124.72% |
| 2009-12-31 | -177.12% |
| 2009-09-30 | -205.96% |
| 2009-06-30 | -234.98% |
| 2009-03-31 | -223.61% |
| 2008-12-31 | -615.48% |
| 2008-09-30 | -301.70% |
| 2004-12-31 | 2.37% |
| 2004-09-30 | -18.01% |
| 2004-06-30 | -14.09% |
| 2004-03-31 | -5.91% |
| 2003-12-31 | -23.05% |
| 2003-09-30 | -16.52% |
| 2003-06-30 | 4.99% |
| 2003-03-31 | -22.98% |
| 2002-12-31 | -11.38% |
| 2002-09-30 | -17.52% |
